Physician profile
John Michael Borzok
NPI 1629422118
$11,262.32
in general payments reported to CMS, 2019-2025
27 companies · $3,016 in 2025
The $3,016 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $367 · 2021: $2,038 · 2022: $2,642 · 2023: $1,969 · 2024: $1,050 · 2025: $3,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,844 · Consulting Fee: $1,750 · Travel and Lodging: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,843.93 |
| Consulting Fee | $1,750.00 |
| Travel and Lodging | $440.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $6,150.96 | 2021-2025 | |
| Stryker Corporation | $1,918.65 | 2020-2025 | Infinity Adaptis, Citrefix, Allowrap |
| Kerecis Limited | $638.04 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $432.58 | 2024-2025 | |
| Integra Lifesciences Corporation | $385.19 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Amgen INC. | $287.66 | 2024-2025 | Krystexxa |
| Seapearl East, INC | $223.24 | 2024-2025 | |
| Horizon Therapeutics Plc | $209.46 | 2020-2022 | |
| Amniox Medical, INC. | $155.84 | 2019-2020 | |
| Extremity Medical | $146.88 | 2025 | |
| Biocomposites INC | $143.18 | 2025 | Stimulan |
| Guard Medical INC. | $113.76 | 2024 | Npseal Large |
| Smith+Nephew, INC. | $81.93 | 2020 | |
| Abbvie INC. | $58.08 | 2023-2025 | Dalvance |
| Zimvie INC. | $35.70 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $35.24 | 2025 | Tirosint, Flector, Licart |
| Paratek Pharmaceuticals, INC. | $33.76 | 2024-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $33.41 | 2025 | Oxistat |
| Electronic Waveform Lab, INC. | $32.35 | 2025 | |
| Embody, INC. | $24.21 | 2021 | |
| Orthofix Medical, INC. | $24.04 | 2025 | Physio-Stim |
| Curonix LLC | $22.10 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Cashflow Solutions, LLC | $17.22 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Wright Medical Technology, INC. | $16.60 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.55 | 2025 | Jublia |
| Xeris Pharmaceuticals, INC. | $14.67 | 2025 | Gvoke Hypopen |
| Baxter Healthcare | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Borzok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.